https://www.astrazeneca-us.com/
AstraZeneca is pushing the boundaries of science to redefine care in hematology. Our goal is to transform outcomes for malignant, rare and other related hematologic diseases through innovative medicines and approaches shaped by patient, caregiver and physician insights. Our therapies are designed to target underlying drivers of disease across multiple scientific platforms.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. For more information, please visit www.astrazeneca-us.com.